| Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet L Malcovati, E Hellström-Lindberg, D Bowen, L Adès, J Cermak, ... Blood, The Journal of the American Society of Hematology 122 (17), 2943-2964, 2013 | 796 | 2013 |
| Prognostic score including gene mutations in chronic myelomonocytic leukemia R Itzykson, O Kosmider, A Renneville, V Gelsi-Boyer, M Meggendorfer, ... Journal of clinical oncology 31 (19), 2428-2436, 2013 | 576 | 2013 |
| Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias R Itzykson, O Kosmider, T Cluzeau, MD Mas, F Dreyfus, O Beyne-Rauzy, ... Leukemia 25 (7), 1147-1152, 2011 | 561 | 2011 |
| Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet MA Sanz, P Fenaux, MS Tallman, EH Estey, B Löwenberg, T Naoe, ... Blood, The Journal of the American Society of Hematology 133 (15), 1630-1643, 2019 | 526 | 2019 |
| Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure T Prébet, SD Gore, B Esterni, C Gardin, R Itzykson, S Thepot, F Dreyfus, ... Journal of Clinical Oncology 29 (24), 3322, 2011 | 520 | 2011 |
| Myelodysplastic syndromes L Adès, R Itzykson, P Fenaux The Lancet 383 (9936), 2239-2252, 2014 | 517 | 2014 |
| Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial C Cordonnier, C Pautas, S Maury, A Vekhoff, H Farhat, F Suarez, ... Clinical infectious diseases 48 (8), 1042-1051, 2009 | 494 | 2009 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 465 | 2020 |
| Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine R Itzykson, S Thépot, B Quesnel, F Dreyfus, O Beyne-Rauzy, P Turlure, ... Blood, The Journal of the American Society of Hematology 117 (2), 403-411, 2011 | 456 | 2011 |
| Luspatercept in patients with lower-risk myelodysplastic syndromes P Fenaux, U Platzbecker, GJ Mufti, G Garcia-Manero, R Buckstein, ... New England Journal of Medicine 382 (2), 140-151, 2020 | 453 | 2020 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 412 | 2022 |
| Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience S Park, S Grabar, C Kelaidi, O Beyne-Rauzy, F Picard, V Bardet, ... Blood, The Journal of the American Society of Hematology 111 (2), 574-582, 2008 | 383 | 2008 |
| Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience L Ades, A Guerci, E Raffoux, M Sanz, P Chevallier, S Lapusan, C Recher, ... Blood, The Journal of the American Society of Hematology 115 (9), 1690-1696, 2010 | 347 | 2010 |
| DNA topoisomerase II in therapy-related acute promyelocytic leukemia AR Mistry, CA Felix, RJ Whitmarsh, A Mason, A Reiter, B Cassinat, ... New England Journal of Medicine 352 (15), 1529-1538, 2005 | 339 | 2005 |
| Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international … J Koreth, J Pidala, WS Perez, HJ Deeg, G Garcia-Manero, L Malcovati, ... Journal of clinical oncology 31 (21), 2662, 2013 | 314 | 2013 |
| Clonal architecture of chronic myelomonocytic leukemias R Itzykson, O Kosmider, A Renneville, M Morabito, C Preudhomme, ... Blood, The Journal of the American Society of Hematology 121 (12), 2186-2198, 2013 | 297 | 2013 |
| A landscape of germ line mutations in a cohort of inherited bone marrow failure patients O Bluteau, M Sebert, T Leblanc, R Peffault de Latour, S Quentin, E Lainey, ... Blood, The Journal of the American Society of Hematology 131 (7), 717-732, 2018 | 290 | 2018 |
| Long-term outcome after bone marrow transplantation for severe aplastic anemia L Ades, JY Mary, M Robin, C Ferry, R Porcher, H Esperou, P Ribaud, ... Blood 103 (7), 2490-2497, 2004 | 273 | 2004 |
| Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF M Jädersten, SM Montgomery, I Dybedal, A Porwit-MacDonald, ... Blood 106 (3), 803-811, 2005 | 257 | 2005 |
| Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia D Selimoglu-Buet, O Wagner-Ballon, V Saada, V Bardet, R Itzykson, ... Blood, The Journal of the American Society of Hematology 125 (23), 3618-3626, 2015 | 255 | 2015 |
